Table 3.
Relationships between β-Catenin Membrane Expression and Clinicopathological Features in Stage I and II Ovarian Carcinomas*
| Preserved β-catenin expression pattern (score 6–7) | Reduced β-catenin membrane expression (score 0–5) | P value | |
|---|---|---|---|
| Histological type | |||
| Endometrioid (n = 13) | 5 (38%) | 8 (62%) | |
| Serous (n = 16) | 1 (6%) | 15 (94%) | |
| Mucinous (n = 23) | 3 (23%) | 20 (77%) | |
| Clear cell (n = 18) | 5 (28%) | 13 (72%) | |
| Mixed (n = 9) | 1 (11%) | 8 (89%) | 0.210 |
| Grade | |||
| I (n = 27) | 8 (30%) | 19 (70%) | |
| II (n = 28) | 5 (17%) | 23 (83%) | |
| III (n = 14) | 2 (14%) | 12 (86%) | 0.431 |
| FIGO stage | |||
| Ia-Ib (n = 23) | 5 (22%) | 18 (78%) | |
| Ic-II (n = 46) | 10 (22%) | 36 (78%) | 1 |
*χ2 test.